tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SRPT Stock Latest News

Sarepta price target raised to $15 from $12 at Leerink
The FlySarepta price target raised to $15 from $12 at Leerink
8d ago
ARWR
SRPT
Sarepta put volume heavy and directionally bearish
PremiumThe Fly
Sarepta put volume heavy and directionally bearish
12d ago
SRPT
Sarepta Therapeutics Restructures Amid ELEVIDYS Challenges
PremiumCompany Announcements
Sarepta Therapeutics Restructures Amid ELEVIDYS Challenges
15d ago
SRPT
Sarepta Therapeutics Completes Convertible Notes Exchange
PremiumCompany Announcements
Sarepta Therapeutics Completes Convertible Notes Exchange
19d ago
8K
SRPT
Sarepta down 10% on new adverse event report, says Deutsche Bank
PremiumThe Fly
Sarepta down 10% on new adverse event report, says Deutsche Bank
21d ago
SRPT
Elanco to replace Sarepta in S&P 400 at open on 9/2
PremiumThe FlyElanco to replace Sarepta in S&P 400 at open on 9/2
21d ago
ELAN
SRPT
Sarepta to replace Brookline Bancorp in S&P 600 at open on 9/2
Premium
The Fly
Sarepta to replace Brookline Bancorp in S&P 600 at open on 9/2
21d ago
BHLB
BRKL
Sarepta financing net negative for equity holders, says H.C. Wainwright
Premium
The Fly
Sarepta financing net negative for equity holders, says H.C. Wainwright
23d ago
SRPT
Sarepta, AST, CoreWeave, Enphase, Paramount: Trending by Analysts
PremiumWeekend Updates
Sarepta, AST, CoreWeave, Enphase, Paramount: Trending by Analysts
25d ago
ASTS
CRWV
Sarepta Therapeutics: Hold Rating Amid Debt Maturity Extension and Strategic Execution Focus
PremiumRatings
Sarepta Therapeutics: Hold Rating Amid Debt Maturity Extension and Strategic Execution Focus
26d ago
SRPT
Walmart reports mixed Q2, Thoma Bravo to acquire Dayforce: Morning Buzz
PremiumThe Fly
Walmart reports mixed Q2, Thoma Bravo to acquire Dayforce: Morning Buzz
27d ago
BA
BZ
Sarepta debt refinancing eases liquidity concerns, says Barclays
PremiumThe Fly
Sarepta debt refinancing eases liquidity concerns, says Barclays
27d ago
SRPT
BofA trims Sarepta price target, says debt refinancing mitigates liquidity risk
PremiumThe FlyBofA trims Sarepta price target, says debt refinancing mitigates liquidity risk
27d ago
SRPT
Sarepta refinances $700M of convertible notes, extends maturities to 2030
Premium
The Fly
Sarepta refinances $700M of convertible notes, extends maturities to 2030
27d ago
SRPT
Sarepta Therapeutics Restructures Debt with New Convertible Notes
Premium
Company Announcements
Sarepta Therapeutics Restructures Debt with New Convertible Notes
27d ago
8K
SRPT
Sarepta Therapeutics Faces Regulatory Challenges and Potential Share Price Decline
PremiumRatings
Sarepta Therapeutics Faces Regulatory Challenges and Potential Share Price Decline
28d ago
SRPT
Citi says FDA may take ‘more comprehensive look’ at Sarepta Elevidys adjustment
PremiumThe Fly
Citi says FDA may take ‘more comprehensive look’ at Sarepta Elevidys adjustment
28d ago
RCKT
SRPT
Sarepta price target raised to $17 from $10 at BofA
PremiumThe Fly
Sarepta price target raised to $17 from $10 at BofA
28d ago
SRPT
Cautious Outlook on Sarepta Therapeutics Amid Uncertain Elevidys Launch and PMO Franchise Risks
PremiumRatings
Cautious Outlook on Sarepta Therapeutics Amid Uncertain Elevidys Launch and PMO Franchise Risks
28d ago
SRPT
High-Risk Concerns Lead to Sell Rating for Sarepta Therapeutics Due to Elevidys Safety Profile
PremiumRatingsHigh-Risk Concerns Lead to Sell Rating for Sarepta Therapeutics Due to Elevidys Safety Profile
30d ago
SRPT
Sarepta says Elevidys Citizen Petition misrepresents treatment-related deaths
Premium
The Fly
Sarepta says Elevidys Citizen Petition misrepresents treatment-related deaths
30d ago
SRPT
Hold Rating on Sarepta Therapeutics Amid Strategic Sale and siRNA Data Uncertainty
Premium
Ratings
Hold Rating on Sarepta Therapeutics Amid Strategic Sale and siRNA Data Uncertainty
1M ago
SRPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >